Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

New kappa-opioid receptor agonists identified at Nippon Chemiphar

April 28, 2021

Pharmacological target for anorexia

April 28, 2021

Vertex to advance VX-548 into phase II development in acute pain

April 28, 2021

Reviva reports strong phase II data in schizophrenia

April 27, 2021

Roflumilast demonstrates cognition-enhancing effects in patients with schizophrenia

April 27, 2021

FDA removes clinical hold on IND application for VY-HTT01

April 27, 2021

Autophagy chaperone targets aggregation-prone proteins

April 27, 2021

Soticlestat reduces frequency of seizures in pediatric patients with DS and LGS

April 27, 2021

A new knock-in mouse model related to spinocerebellar ataxia 14

April 27, 2021

Shanghai Newsky Biotechnology presents new PLA2G7 inhibitors

April 26, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...